Poorly predictive animal models of disease cause avoidable suffering and hamper the discovery of new treatments for patients. A focus on mechanistic modelling has the potential to reduce animal suffering as well as improving translation from the bench to the bedside.
Get full access to this article
View all access options for this article.
References
1.
IoannidisJ. (2012). Extrapolating from animals to humans. Science Translational Medicine4, 1–3.
2.
PoundP., & BrackenM. (2014). Is animal research sufficiently evidence based to be a cornerstone of biomedical research?British Medical Journal, 348, g3387.
3.
McGrathJ., McLachlanE., & CurtisM. (2014). How predictive and productive is animal research?British Medical Journal, 348, g3719.
4.
GarnerJ.P., GaskillB.N., WeberE.M., Ahloy-DallaireJ., & Pritchett-CorningK.R. (2017). Introducing therioepistemology: The study of how knowledge is gained from animal research. Lab Animal46, 103–113.
5.
FrancoR., & Cedazo-MinguezA. (2014). Successful therapies for Alzheimer's disease: Why so many in animal models and none in humans?Frontiers in Pharmacology, 5, 1–13.
6.
O'CollinsV.E., MacleodM.R., DonnanG.A., HorkyL.L., van der WorpB.H., & HowellsD.W. (2006). 1,026 experimental treatments in acute stroke. Annals of Neurology59, 467–477.
7.
HunterJ. (2011). Have animal models of disease helped or hindered the drug discovery process?Annals of the New York Academy of Sciences, 1245, 1–2.
MorganP., & Van der GraafP. (2012). Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving phase II survival. Drug Discovery Today17, 419–424.
10.
LilleyE., & JenningsM. (2013). Refinement: Lessons from the 2012 Olympics. ATLA41, P28–P29.
